SOAT1 and myeloproliferative neoplasm: To extend our findings to the Jak2V617F hematopoietic cellular context, thus mimicking patients for whom RAS pathway mutations are harbored within the JAK/STAT activated MPN driver clone such as Patient#4 in Fig. 3C, we performed a second in vivo competition experiment.